Introduction
============

Five randomized clinical trials demonstrated a beneficial effect of endovascular therapy in anterior circulation stroke patients \[[@B1][@B3][@B4][@B5]\]. The standard technique to select patients for a mechanical thrombectomy consists of a CT angiography, proving a major vessel occlusion. CT perfusion (CTP) is another technique that can be used for this selection. CTP provides physiological information of the infarcted area and the surrounding penumbra that remains potentially viable. CTP may differentiate between patients in whom recanalization would be futile and patients with a significant penumbra to be rescued. CTP has found general acceptance but the extent to which it can improve patient selection is still debated. We wanted to explore whether patients' outcomes had changed after the introduction of CTP. The presented study was conducted retrospectively in a group of stroke patients receiving thrombectomy after CTP following the study period used in an early report of thrombectomy outcome \[[@B6]\].

Methods and Materials
=====================

Study design
------------

This single-centre study was designed to examine whether the outcome of mechanical thrombectomy would improve when based on CTP. Between January 1st 2014 and the 31st of December 2015, all patients with a major vessel occlusion in the anterior circulation treated by mechanical thrombectomy after CTP were included. This study was conducted retrospectively, comprising a time period following a period used in an early multicentric study from the same region without CTP selection. The present study was approved by the local ethics committee (B670201630032 & B670201630033).

Inclusion criteria
------------------

All patients who suffered from acute ischemic stroke in the anterior (internal carotid artery \[ICA\] and middle cerebral artery \[MCA\]) circulation who had a thrombectomy were included. CT angiography was required to prove a major vessel occlusion. Treatment with IV rtPA before starting an endovascular intervention was allowed.

Exclusion criteria
------------------

There was no age limit, nor were there specified exclusion criteria for comorbidity. No patients were excluded based on the severity of the stroke, as measured with the National Institutes of Health Stroke Scale (NIHSS). A six-hour time window for non-wake-up strokes was applied, although a deviation was allowed on a case-by-case basis. For wake-up strokes, onset time was not available and therefore no window could be applied.

Patients who did not receive a CTP scan were excluded from this study. The interventional radiologist and neurologist decided on the basis of this CTP if the patient was eligible for a mechanical thrombectomy. If there was a mismatch on the CTP with at least approximately 1/3 of the affected area supposed to be penumbra, then the patient received thrombectomy.

Procedure of the mechanical thrombectomy
----------------------------------------

A Solitaire® stent retriever (Medtronic) was used for the mechanical thrombectomy. Patients who were treated before May 2015 were put on heparin anticoagulation during the intervention. From May 2015 on, patients no longer received heparin. Patients were administered local anaesthesia, except when unstable or restless. In those cases, we decided to perform the thrombectomy under general anaesthesia with intubation.

Data collection
---------------

The following patient data were obtained from medical records: age; sex; location of the occlusion; treatment with rtPa; NIHSS (pre-procedural); mRS at 3 and 12 months; time between symptom onset and procedure start, the moment of incision ("onset-to-groin"); time between symptom onset and reperfusion ("onset-to-reperfusion"); the duration of the endovascular procedure and the use of a pre-procedural MRI (perfusion and diffusion) in patients with a WUS. Patients with a WUS were not included in analysis of the "onset-to-groin" and "onset-to-reperfusion" intervals. The time of procedure start was retrieved from the anaesthesiologist's report.

Neuro-imaging analysis
----------------------

The modified treatment in cerebral infarction (mTICI score) was used to measure the reperfusion grade post thrombectomy (Table [1](#T1){ref-type="table"}).

###### 

mTICI (modified treatment in cerebral infarction) score.

  ------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Grade   Angiographic definition
          
  0       no reperfusion
  1       antegrade reperfusion past the initial occlusion, but limited distal branch filling with little or slow distal reperfusion
  2a      antegrade reperfusion of less than half of the occluded target artery previously ischemic territory (e.g. in one major division of the middle cerebral artery (MCA) and its territory)
  2b      antegrade reperfusion of more than half of the previously occluded target artery ischemic territory (e.g. in two major divisions of the MCA and their territories)
  3       complete antegrade reperfusion of the previously occluded target artery ischemic territory, with absence of visualised occlusion in all distal branches
  ------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison with the non-CTP study
---------------------------------

We compared the presented results with those of anterior circulation thrombectomy as described in the study of Fockaert et al. \[[@B1]\]. The non-CTP study took place in the same region as our study; but in a time before CTP was implemented as a selection method in the acute stroke protocol.

Outcome
-------

The modified Rankin Scale (mRS) was used to measure functional outcome. The primary endpoint of this study was a good functional outcome (GFO) defined as mRS 0--2 at 90 days, obtained by the treating neurologist not blinded for the result of the mechanical thrombectomy. Secondary outcomes were clinical significant haemorrhage, excellent functional outcome (EFO) defined as mRS 0--1 at 90 days, mortality at 90 days and GFO, EFO and mortality at one year. Intracranial haemorrhage was determined on the CT scan 24 hours after the endovascular procedure.

Statistical analysis
--------------------

The location of the occlusion was dichotomized into the anterior circulation: ICA and/or MCA. The mTICI scores were dichotomized into a substantial reperfusion (mTICI 2b--3) versus low reperfusion (mTICI 0--2a). P-values ≤ 0.05 were considered significant. Univariate and multivariate analysis (with GFO and EFO as outcome variables) were performed. Wake-up strokes were included in the multivariate analysis; but not the intervals "onset to groin" and "onset to reperfusion" as parameter. SPSS24.0 was used to perform statistical analysis \[[@B2]\].

Results
=======

Eight-nine patients with an anterior ischemic stroke underwent a mechanical thrombectomy. Two patients did not consent and were excluded. Eleven patients did not receive a CTP or the CTP could not be interpreted due to patient movement or contrast leakage. These patients were excluded.

We report on 76 patients who had an occlusion in the anterior circulation: 3 ICA (3.9%), 65 MCA (85.5%) and 8 (10.5%) with a tandem (ICA + MCA) occlusion. Baseline characteristics are summarized in Table [2](#T2){ref-type="table"}.

###### 

Baseline characteristics of all included patients.

  --------------------------------- ------------------------------ ------------------ ------------- -------------- ----------------
  Parameter                                                        Overall (N = 76)   ICA (N = 3)   MCA (N = 65)   Tandem (N = 8)
                                                                                                                   
  Age (years)                       Median (IQR)                   69.5 (19.5)        63 (--)       70 (22)        72.5 (18)
  Gender -- no. (%)                 Man                            31 (40.8)          1 (33.3)      25 (38.5)      5 (62.5)
  Woman                             45 (59.2)                      2 (66.7)           40 (61.5)     3 (37.5)       
  NIHSS score                       Median (IQR)                   16 (6)             17 (--)       16 (6)         19(4)
  Stroke cause -- no (%)            Large artery atherosclerosis   3 (3.9)            0 (0)         2 (3,1)        1 (12.5)
  Cardio-embolism                   41 (53.9)                      1 (33.3)           34 (52.3)     6 (75)         
  Other determined etiology         7 (9.2)                        0 (0)              7 (10.8)      0 (0)          
  Undetermined etiology             25 (32.9)                      2 (66.7)           22 (33.8)     1 (12.5)       
  Intravenous rtPA -- no (%)                                       59 (77.6)          2 (66.7)      50 (76.9)      7 (87.5)
  Time onset to groin (min)         Median                         260                285           260            220
  Time onset to reperfusion (min)   Median                         356                379           355            371
  Duration thrombectomy (min)       Median                         90                 94            89             86
  Wake-up stroke (%)                                               12 (15.8)          0 (0)         10 (15.4)      2 (25)
  Intravenous heparin                                              19 (25)            0 (0)         17 (26.2)      2(25)
  --------------------------------- ------------------------------ ------------------ ------------- -------------- ----------------

ICA internal carotid artery, MCA medial middle cerebral artery, NIHSS National Institutes of Health Stroke Scale.

Data of the functional outcome at three months was obtained from 64 (84.2%) patients. Thirty-one of the 64 patients (48.4%) had a GFO and 22 (34.4%) had an EFO. The mortality rate at three months was 14.5% (11 of 76 patients). Data regarding intracranial haemorrhage was obtained in 74 patients (97.4%). Ten patients had an intracranial haemorrhage (13.5%); three of those were of clinical significance (4.1% of all patients) (Figure [1](#F1){ref-type="fig"}).

![Modified Rankin Scale Scores at 90 days and at 1 year.](jbsr-104-1-1944-g1){#F1}

In 63 of the 64 patients (98.4%) without a WUS, the time interval from onset-to-groin was documented. Median onset-to-groin interval was 260 minutes. 8 (12.5%) patients had an interval greater than six hours. The time interval from onset-to-reperfusion was documented in 63 of 64 cases (98.4%). Median onset-to-reperfusion interval was 356 minutes. The duration of the procedure was known in all 76 cases; the median time was 90 minutes (range 37/289).

No significant association could be found between the onset-to-groin interval and the GFO, EFO or mortality at three months. Respective p-values were 0.569; 0.800 and 0.940. After eliminating patients with a time window of six hours or more, the non-association between the onset-to-groin interval and the GFO, EFO or mortality at three months remained (Respective p-values were 0.559; 0.992 and 0.677).

A significant association was found between the onset-to-reperfusion interval and GFO (p = 0.042). If the duration was shorter, then more patients had a GFO. No significant association was found with mortality (p = 0.553) and EFO (p = 0.107).

A significant association was found between the procedure duration and the EFO (p = 0.032). There were more patients with an EFO if the duration of the procedure was shorter (p = 0.074). No significant association was found regarding GFO or mortality (p = 0.063).

GFO and EFO did not differ between WUS and non-WUS (p = 0.268; p = 0.490). A similar number of intracranial haemorrhages were found in WUS (16.7%) and non-WUS (12.9%) (p = 0.661). Five of the twelve people with a WUS received an MRI pre-procedure.

A substantial reperfusion (mTICI 2b or 3) was achieved in 68 of 76 (89.5%) patients. Five patients had a mTICI0, 3 mTICI2a; 17 mTICI2b and 51 mTICI3. No significant association was found between the outcome and the achievement of a substantial reperfusion. P-values were: 0.053 for GFO; 0.155 for EFO and 0.085 for mortality. There were no patients who did not have a substantial reperfusion but did have a GFO or EFO (Figure [2](#F2){ref-type="fig"}).

![Modified Rankin Scale at three months categorized by mTICI score.](jbsr-104-1-1944-g2){#F2}

There was no significant association between the administration of IV thrombolysis and the occurrence of a clinical significant haemorrhage (p = 1.000). All patients with a clinical significant haemorrhage had received IV thrombolysis.

In a multivariate model on GFO, we added the variables age, sex, administration of rtPA, NIHSS before treatment, the time of the procedure, reperfusion, general anaesthesia, heparin administration and parenchymal hematoma. The variables that significantly predicted GFO were administration of rtPA (p = 0.019), time of the procedure (p = 0.006), administration of heparin (p = 0.009) and NIHSS before treatment (p = 0.004). In the multivariate analysis for EFO the only variable that could be retained in the final model was NIHSS before treatment (p = 0.009). A lower NIHSS before treatment was a predictor of an EFO.

Functional outcome at one year was obtained from 67 (88.2%) patients. Thirty (44.8%) had a GFO and 21 (31.3%) had an EFO. The mortality at one year was 22.4% (17 of 76 patients). There was no significant difference between the number of patients with a GFO at three months and at one year (p = 1.000). No difference was found between the number of patients with the EFO at three months and at one year (p = 1.000).

Comparison with non-CTP study
-----------------------------

The majority of demographics, stroke characteristics and outcome in the present study and the study of Fockaert et al. are comparable (Table [3](#T3){ref-type="table"}).

###### 

Comparison of demographics and results of our study and the part of study of Fockaert et al. studying occlusions in the anterior circulation.

  ------------------------------------------- ------------------------ --------------------------
                                              Present study (n = 76)   Fockaert et al. (n = 65)
                                                                       
  Demographics                                                         
      Median age                              69.5                     64
      Substantial reperfusion                 89.6%                    72%
      Sex (male)                              40.8%                    34%
      Median NIHSS on admission in hospital   16                       15
      rtPA                                    77.6                     60
      Onset to groin                          260                      252
  Outcome                                                              
      GFU                                     48.4%                    44%
      EFU                                     34.4%                    29%
      Mortality                               14.5%                    22%
      Significant ICH                         3 (4,1%)                 4 (5%)
  ------------------------------------------- ------------------------ --------------------------

Discussion
==========

In patients with a stroke by a major vessel occlusion and who had undergone CTP and thrombectomy, GFO at three months was 48.4% and EFO was 34.4%. In this selected group of stroke patients, the mortality at three months was 14.5%, and 4.1% of patients had a significant ICH.

CTP was introduced to select patients with a higher probability to benefit from a mechanical thrombectomy. Additionally, by evaluating CTP, we would also be able to exclude patients from a thrombectomy procedure when major infarction was established and penumbra limited. However, the outcome improvement compared to a similar retrospective multicentric study that did not use CTP, was only mild (GFO 48.4% versus 44%; EFO 34.4% versus 29%) \[[@B1]\]. This monocentric study was conducted in the same area, so that the presented study can be considered as a sequel of the original but with additional CTP as a selection method.

The explanation why the expected better outcome at three months was not observed is multifactorial. Firstly, the time period of inclusion reflects the early days of experience with CTP. CTPs were visually read out by the radiologist and communicated to the neurologist and interventional radiologist. The interpretation was done in consensus, but the infarct volume and penumbra were not quantified. The penumbra threshold was visually determined by 1/3 of the affected area (on CBF and CBV). Therefore, evaluation of CTP was not yet standardized and probably interpreted in a way to offer maximum chances to a maximum of patients, leading to an overoptimistic inclusion.

Secondly, the work-flow around the CTP and its interpretation could have increased the onset-to-groin time. This seems not the case, as the onset-to-groin time was similar in the retrospective study without CTP (260 vs. 252 minutes) \[[@B1]\].

In a meta-analysis performed by Ryu et al. mechanical thrombectomy resulted in a higher number of GFO in patients selected by CTP (51.1% versus 45.6%; p = 0.06) \[[@B8]\]. However, significancy was only observed for a subgroup of patients with a specified onset time (OR 1.3; p \< 0.01), and not for patients with an unknown onset time (OR 1.08; p = 0.66). From this review, it could not be concluded that CTP was of benefit for all candidates for thrombectomy. It is remarkable that for unknown time of onset (or wake up) strokes the use of CTP did not result in a selection of patients that would benefit most. In the presented study, strokes with known and unknown onset were included. The presented GFO results lie between the GFO of the "intervention" group with CTP and the control group of the meta-analysis \[[@B8]\].

Five RCTs showed that mechanical thrombectomy in stroke patients for an occlusion in the anterior circulation leads to a better functional result than the standard treatment \[[@B3][@B4][@B5][@B6][@B7]\]. The study that used a CTP for the selection of patients was the study with the highest percentage of GFO (EXTEND-IA: 71%). The CTP was processed with the use of fully automated software (RAPID) \[[@B6]\]. A quantitative analysis of the infarct core and penumbra seems more efficient for selection of good candidates for thrombectomy. An automated analysis of the images with standardised algorithms (either Philips, Siemens, Olea or RAPID) is now implemented in our department, in combination with the clinical NIHSS score.

Mortality in the presented study was lower than in the non-CTP study (14.5% versus 22%) \[[@B1]\]. Whether CTP was adequate to exclude patient with a malignant MCA infarction, hence could have reduced mortality, is not clear. We have not registered the patients with an unfavourable CTP. Also, a higher reperfusion rate (TICI3 and 2B of 89.6% compared with 72%) and a higher percentage of patients receiving rtPA (77.6% compared with 60%) in the presented study could have reduced infaust outcomes 1). A recent study regarding the role of intravenous thrombolysis (IVT) prior to mechanical thrombectomy, did not find IVT to be an independent predictor of good functional outcome, low mortality or high recanalization rates \[[@B9]\].

In our study, no association was found between onset-to-groin time and the mRS outcome at three months. The time to reperfusion, however was significantly associated with GFO at three months but not with EFO at three months. Subsequently, one could calculate and expect that the duration of the procedure would be associated with the mRS outcome. This was only true for the EFO at three months, and not for the GFO. A distinct time between the onset of symptoms and procedure start has always been used as a selection criterium for IV and endovascular therapy \[[@B10]\]. Why this was not found in the presented study might be explained by a variation in the registered time period. For this study, procedure start was retrieved from the anaesthesiologist's report, which might not always be identical to the puncture time. Also possible is that by introducing CTP in the selection algorithm, the value of "time" as a predictor of functional outcome has diminished. In studies that did not use CTP, a shorter "onset-to-groin" has been found to be strongly associated with a better functional outcome at three months \[[@B9]\]. When CTP was used as a selection method, this association was not found \[[@B10]\]. The shorter the thrombectomy procedure the better is the expected outcome. Longer procedure duration can result in complications due to anaesthesia or manipulations \[[@B11]\]. Patients with a longer procedural duration are less likely to have a complete recanalization \[[@B12]\]. In our department we decided after the study that the mechanical thrombus retrieval should be done within two hours, otherwise the procedure will be stopped.

There was no significant difference in outcome to be found between WUS and non-WUS. This can signify that CTP might be a good selection method for decision making on endovascular stroke treatment in patients with an unknown time of symptom onset. A recent study by Caruso confirmed that CTP is a good method for selecting WUS patients who could benefit from endovascular therapy \[[@B13]\].

A substantial reperfusion (TICI III and 2B) was achieved in 89.6% of patients. This excellent result was comparable with reperfusion rates observed in RCTs. In contrast to these RCTs, a significant increase in patients with GFO at three months was not found. Other RCTs did report higher percentage of good mRS scores at three months: e.g. SWIFT PRIME (88% reperfusion; 60% GFO) and EXTEND-IA (86% reperfusion; 71% GFO) \[[@B5][@B7]\]. It might be that the substantial reperfusion rate in the presented study is overestimated while only based on the radiological reports. In other studies \[[@B1][@B3][@B4][@B5][@B6][@B7]\], mTICI scores were read out blinded in by two independent raters. Also very few patients in our study had a low reperfusion rate; thus limiting the statistical power. It should be noted that not a single person with "low reperfusion" had a GFO at three months.

There are some limitations to this study. It is conducted retrospectively, with a relative low number of patients. The drop out ratio because of unknown mRS score at three months (15.8%) or because of a WU stroke (15.7%) is substantial. There was no quantitative analysis of CTP (infarct core and penumbra) and no blinded analyses of the post thrombectomy reperfusion (TICI).

Our study has some clear strengths. Every patient received a CTP prior to endovascular treatment and no hard exclusion criteria regarding comorbidities or age were applied. Thus, the results represent a real life experience for endovascular treatment. The study took place in a major centre for invasive stroke treatment, in a region of another early report of intracranial thrombectomy, so comparison of outcome evolution after introduction of CTP is possible.

Conclusion
==========

CTP with visual analysis as a decision-making method only marginally improved selection of good candidates for a mechanical thrombectomy in anterior circulation strokes. To determine the added value of a CTP, it should probably be examined in a quantitative way and in a RCT. Based on the result of our study that shorter procedure duration was associated with a better outcome, we recommend limiting all future endovascular thrombus retrievals to two hours.

Abbreviations
=============

  -------------- --------------------------------------------
  Abbreviation   Explanation
                 
  CTP            CT perfusion
  RCT            randomized controlled trial
  GFO            good functional outcome
  EFO            excellent functional outcome
  NIHSS          National Institutes of Health Stroke Scale
  mTICI score    modified treatment in cerebral infarction
  mRS            modified Rankin Scale
  ICA            internal carotid artery
  MCA            middle cerebral artery
  rtPA           recombinant tissue plasminogen activator
  WUS            wake-up stroke
  CBF            cerebral blood flow
  CBV            cerebral blood volume
  -------------- --------------------------------------------
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